Pomelo Capital’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$6.48M Hold
227,800
0.62% 37
2018
Q2
$7.65M Sell
227,800
-3,300
-1% -$103K 0.75% 34
2018
Q1
$5.58M Sell
231,100
-232,700
-50% -$4.63M 0.3% 56
2017
Q4
$7.62M Hold
463,800
0.23% 74
2017
Q3
$7.62M Hold
463,800
0.25% 78
2017
Q2
$8.97M Buy
463,800
+5,000
+1% +$87.2K 0.39% 53
2017
Q1
$8.13M Buy
458,800
+125,100
+37% +$2.32M 0.41% 54
2016
Q4
$9.65M Buy
333,700
+194,700
+140% +$3.49M 0.43% 66
2016
Q3
$4.02M Buy
+139,000
New +$3.62M 0.18% 97

Other funds holding THC

Pomelo Capital's THC Position: Q2 2018 in Review

Pomelo Capital sold out of Tenet Healthcare (THC) in Q2 2018, closing a stake of 53,472 shares — an estimated $1.66M sold.

Pomelo Capital first reported a position in THC in Q4 2016 and held it in 6 quarters. The position peaked at $2.63M in Q4 2017. 253 funds tracked by Wall St. Rank hold THC as of Q2 2018.

  • Pomelo Capital reported no remaining Tenet Healthcare position as of Q2 2018 after selling out during the quarter.
  • Pomelo Capital sold 53,472 Tenet Healthcare shares in Q2 2018, an estimated $1.66M.
  • Pomelo Capital first reported a position in Tenet Healthcare in Q4 2016 and held it in 6 quarters.
  • Pomelo Capital's Tenet Healthcare position peaked at $2.63M in Q4 2017.
  • 253 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2018.

Based on Pomelo Capital's 13F filing for Q2 2018, filed 14 Aug 2018.